Cortechs.ai, a pioneer in AI-driven healthcare solutions, proudly announces a major update for its flagship product, NeuroQuant® v5.0, which is currently FDA 5
Share this article
Share this article
SAN DIEGO, Jan. 14, 2021 /PRNewswire/ Cortechs.ai is pleased to announce the appointment of its new vice president of sales, Josh Cohen. The new appointment follows the acquisition of sister company Healthlytix and a company rebrand from CorTechs Labs to Cortechs.ai. Cortechs.ai is a leader in AI applications in radiology with FDA-cleared products for improved detection of neurodegenerative disease and cancer.
Josh brings over 12 years of proven commercial sales and leadership success. With expertise in business development and sales strategies in both large hospital health systems and outside the hospital space, Josh has a deep focus on integrated radiology solutions, informatics, and artificial intelligence to help healthcare providers deliver improved outcomes at a lower cost.